Allergy medication efficacy
Pro Research Analysisby 
Searched over 200M research papers
Efficacy of Allergy Medications for Allergic Rhinitis and Asthma
Pharmacotherapy for Allergic Rhinitis: Intranasal Corticosteroids, Antihistamines, and Montelukast
Pharmacotherapies such as intranasal corticosteroids (INCS), intranasal antihistamines, oral antihistamines, and montelukast are all effective in reducing nasal symptoms in patients with seasonal and perennial allergic rhinitis. Among these, INCS and combination intranasal antihistamine/INCS treatments show the greatest improvement in total nasal symptom scores compared to placebo, followed by intranasal antihistamines, oral antihistamines, and montelukast. All these treatments are significantly better than placebo, but direct comparisons between classes are limited due to trial differences and potential publication bias Meltzer2021Sousa-Pinto2024.
Allergen Immunotherapy: Sublingual, Subcutaneous, and Oral Routes
Allergen immunotherapy (AIT), including sublingual (SLIT), subcutaneous (SCIT), and oral immunotherapy, is effective for allergic rhinitis, asthma, and other respiratory allergies. Both SLIT and SCIT are particularly effective for aeroallergens like pollen and house dust mites, with SCIT sometimes showing higher efficacy for house dust mite allergies. SLIT is generally safer and well-tolerated, making it suitable for a wide range of patients, including children and the elderly. Oral immunotherapy is especially effective for food allergies and is the only approved method for elderly patients due to its low risk of side effects Baba2021Lisiecka2025Li2024.
Long-Term and Real-World Effectiveness of Immunotherapy
Long-term studies and real-world data confirm that both SCIT and SLIT lead to sustained reductions in allergy symptoms and medication use, with benefits lasting up to seven years for some treatments. Persistence with immunotherapy is associated with greater reductions in allergy prescriptions, and both grass and house dust mite-specific immunotherapies are effective, while tree-specific immunotherapy may be less so. Rates of serious adverse events, such as anaphylaxis, are very low, especially with SLIT tablets Contoli2023Baba2021Li2024.
Combination Therapies: Immunotherapy Plus Biologics
Combining allergen immunotherapy with biologic agents, such as omalizumab (an anti-IgE antibody), further increases treatment efficacy and safety. This combination reduces the need for emergency medications, decreases severe nasal symptoms, and lowers the risk of serious adverse reactions compared to immunotherapy or biologics alone. These benefits are seen in both allergic rhinitis and asthma, making combination therapy a promising option for patients with more severe or difficult-to-treat allergies Bozek2023Guan2025.
Accelerated and Combination Immunotherapy Approaches
Rush immunotherapy (RIT), which shortens the up-dosing phase of treatment, combined with a single dose of anti-IgE, provides faster symptom relief, better patient compliance, and similar safety compared to conventional immunotherapy. This approach is particularly useful in pediatric patients, offering practical advantages without increasing costs .
Drug Allergy Management: Desensitization and Graded Challenges
For drug allergies, desensitization protocols and graded challenges are highly effective in enabling patients to tolerate necessary medications. Desensitization has a high success rate, while graded challenges are also effective but slightly less so. Using alternative medications reduces the risk of allergic reactions but may not always provide the same treatment efficacy .
Conclusion
Allergy medications, including pharmacotherapies and various forms of immunotherapy, are effective in reducing symptoms and improving quality of life for patients with allergic rhinitis, asthma, and other allergies. Intranasal corticosteroids and combination therapies are particularly effective for nasal symptoms, while both sublingual and subcutaneous immunotherapies offer long-term benefits. Combining immunotherapy with biologics or using accelerated protocols can further enhance efficacy and safety. For drug allergies, desensitization and graded challenges are valuable management strategies. Overall, the choice of therapy should be tailored to the patient’s specific allergy type, severity, and individual needs Meltzer2021Contoli2023Sousa-Pinto2024+7 MORE.
Sources and full results
Most relevant research papers on this topic